首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities
【24h】

Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities

机译:双环二肽螺旋藻丝抑素C和D的全合成及其组蛋白脱乙酰基酶抑制和抗增殖活性的研究

获取原文
获取原文并翻译 | 示例
       

摘要

The bicyclic depsipeptide histone deacetylase (HDAC) inhibitors spiruchostatins C and D were synthesized for the first time in a highly convergent and unified manner. The method features the amide coupling of a d-leucine-d-cysteine- or d-valine-d-cysteine-containing segment with a d-alanine- or d-valine-containing segment to directly assemble the corresponding seco-acids, key precursors of macrolactonization. The HDAC inhibitory assay and cell-growth inhibition analysis of the synthesized depsipeptides determined the order of potency of spiruchostatins A-D in comparison with the clinically approved depsipeptide FK228 (romidepsin). Novel aspects of structure-activity relationships (SAR) were revealed.
机译:双环二肽组蛋白去乙酰化酶(HDAC)抑制剂spiruchostatins C和D首次以高度收敛和统一的方式合成。该方法的特点是将含有d-亮氨酸-d-半胱氨酸或d-缬氨酸-d-半胱氨酸的片段与含有d-丙氨酸或d-缬氨酸的片段进行酰胺偶联以直接组装相应的癸二酸,关键大内酯化的前兆。合成的大肽肽的HDAC抑制分析和细胞生长抑制分析确定了螺旋藻抑素A-D与临床批准的大肽肽FK228(romidepsin)相比的效力顺序。揭示了结构-活性关系(SAR)的新颖方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号